Lack of association between mutations in the folate receptor-a gene and spina bifida

American Journal of Medical Genetics

Volumn 76, Issue 4, 1998, Pages 310-317

  Barber, Robert C ^a   Shaw, Gary M ^b   Lammer, Edward J ^c   Greer, Kimberly A ^a   Biela, Timothy A ^a   Lacey, Steven W ^d   Wasserman, Cathy R ^e   Finnell, Richard H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Folate receptor alpha; Folic acid; Neural tube defects

Indexed keywords

FOLIC ACID; VITAMIN RECEPTOR;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA SEQUENCE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NEWBORN; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SPINA BIFIDA;

CARRIER PROTEINS; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DNA FINGERPRINTING; EXONS; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA; SPINAL DYSRAPHISM; TETRAHYDROFOLATES; VARIATION (GENETICS);

EID: 0032054038     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Andersen RGW, Kamen BA, Rothberg KG, Lacey SW (1992): Potocytosis: Sequestration and transport of small molecules by caveolae. Science 255:410-411.
2. Bower C, Stanley FJ (1989): Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Med J Aust 150:613-619.
3. Burk RF, Hill KE (1993): Regulation of selenoproteins. Annu Rev Nutr 13:65-81.
4. Campbell KG, Jones TA, Foulkes WD, Trowsdale J (1991): Folate-binding protein is a marker for ovarian cancer. Cancer Res 51:5329-5338.
5. Campbell LR, Dayton DH, Sohal GS (1986): Neural tube defects: A review of human and animal studies on the etiology of neural tube defects. Teratology 34:171-187.
6. Carter CO, David PA, Laurence KM (1968): A family study of major central nervous system malformations in South Wales. J Med Genet 5:81-106.
7. Chanarin I, Deacon R, Lumb M, Perry J (1992): Cobalamin and folate: Recent developments. J Clin Pathol 45:277-283.
8. Chung KN, Paik TH, Roberts S, Kirn CH, Kirassova M, Weinstein JN, Trepel JB, Elwood PC (1994): Site-directed mutagenesis of tryptophan residues to conserved hydrophobic residues inhibits the processing of human KB cell receptor. Arch Biochem Biophys 315:407-414.
9. Copp AJ, Brook FA, Estibeiro JP, Shum ASW, Cockroft DL (1990): The embryonic development of mammalian neural tube defects. Prog Neurobiol 35:363-403.
10. Czeizel AE, Dudâs I (1992): Prevention of the first occurrence of neuraltube defects by periconceptual vitamin supplementation. N Engl J Med 327:1835-1835.
11. de Araujo M, Sanches MR, Suzuki LA, Guerra G Jr, Farah SB, de Mello MO (1996): Molecular analysis of CYP21 and C4 genes in Brazilian families with the classical form of steroid 21 hydroxylase deficiency. Braz J Med Biol Res 29:1-13.
12. Elwood PC (1989): Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J Biol Chem 264:14893-14901.
13. Finnell RH, Greer KA, Barber RC, Piedrahita JA, Shaw GM, Lammer EJ (1998): Neural tube and craniofacial defects with special emphasis on on folate pathwaygenes. Crit Rev Oral Biol Med 9:38-53.
14. Folch JM, Coll A, Hayes HC, Sanchez A (1996): Characterization of a caprine beta-lactoglobulin pseudogene, identification and chromosomal localization by in situ hybridization in goat, sheep and cow. Gene 177: 87-91.
15. Gross S, Kamen B, Fanaroff A, Gaston D (1980): Folate compartments during gestational maturation. J Pediatr 96:842-844.
16. Hall JG, Friedman JM, Kenna BA, Popkin J, Jawanda M, Arnold W (1988): Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet 43:827-837.
17. Journel H, Roussey M, Dabadie A, Le Marec B (1985): Malformations du tube neural et jumeaux. J Gynecol Obstet Biol Reprod 14:819-827.
18. Kamen BA, Smith AK, Anderson RGW (1991): The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro. J Clin Invest 87:1442-1449.
19. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RGW (1988): Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602-13609.
20. Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM (1996): Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348:1037-1038.
21. Lacey SW, Sanders JM, Rothberg KG, Anderson RG, Kamen BA (1989): Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J Clin Invest 84:715-720.
22. Laurence KM, James N, Miller MH, Tennant GB, Campbell H (1981): Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 282:15091511.
23. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Waiden ME, Depp OR, Hoffman HJ (1989): The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 321:430-435.
24. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W (1989): Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847-285,2.
25. MRC Vitamin Study Research Group (1991): Prevention of neural tube defects: Results of the MRC vitamin study. Lancet 338:131-137.
26. Mulinare J, Cordero JF, Erickson JD, Berry RJ (1988): Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-3145.
27. Orr RB, Kamen BA (1995): Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype. Cancer Res 55:847-852.
28. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr (1996): 5, 10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
29. Papapetrou C, Lynch SA, Burn J, Edwards YH (1996): Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:348-358.
30. Popadic A, Norman RA, Doanet WW, Anderson WW (1996): The evolutionary history of the amylase multigene family in Drosophila pseudoobscura. Mol Biol Evol 13:883-888.
31. Qiang L, Sommer S (1994): Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP. PCR Methods Applications 4:97108.
32. Ragoussis J, Senger G, Trowsdale J, Campbell IG (1992): Genomic organization of the human folate receptor genes on chromosome llqlS. Genomics 14:423-430.
33. Ritter TE, Fajardo O, Matsue H, Anderson RG, Lacey SW (1995): Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake. Proc Natl Acad Sei USA 92:3824-3828.
34. Rosenblatt DS (1989): Inherited disorders of folate transport and metabolism. In Scriver CR, Beaudet AL, Sly AS (eds): "The Metabolic Basis of Inherited Diseases." New York: McGraw-Hill, pp 3111-3128.
35. Ross JF, Chaudhuri PK, Ratnam M (1994): Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 73:2432-2443.
36. Sambrook J, Fritsch EF, Maniatis T (1988): "Molecular Cloning, A Labo- ratory Manual," 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 1.38-1.38, 1.53-1.73
37. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sei USA 74:5463-5467.
38. Sarkar G, Yoon HS, Sommer SS (1992): Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13441-443.
39. Seller, MJ (1995): Recent developments in the understanding of the aetiology of neural tube defects. Clin Dysmorphol 4:93-104.
40. Shaw GM, Schaffer D, Velie E, Morland KM, Harris JA (1995): Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
41. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP (1980): Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1:339-340.
42. Steegers-Theunissen RP (1995): Folate metabolism and neural tube defects: A review. Eur J Obstet Gynecol Repro Biol 61:39-48.
43. Trabesinger-Ruef N, Jerman T, Zankel T, Durrant B, Frank G, Benner SA (1996): Pseudogenes in ribonuclease evolution: A source of new biomolecular function? FEES Lett 383:319-322.
44. Trembath D, Sherbondy A, VanDyke D, Finnell R, Marker S, Murray JC (1996): Analysis of the folate pathway genes, human T and Pax 3 in a midwestern neural tube defect population. Am J Hum Genet 59:144.
45. Tusié-Luna MT, Ramirez-Jiménez S, Ordônez-Sânches ML, CabelloVillegas J, Altamirano-Bastamante N, Calzada-Leôn R, Robles-Valdés C, Mendoza-Morfïn F, Méndez JP, Terân-Garcia M (1996): Low frequency of deletion alleles in patients with steroid 21-hydroxylase deficiency in a Mexican population. Hum Genet 98:376-379.
46. Tusié-Luna MT, White PC (1995): Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sei USA 92:10796-10800.
47. Van Alien MI, Kalousek DK, Chemoff GF, Juriloff D, Harris M, McGil-livray BC, Yong S-I, Langlois S, MacLeod PM, Chitayat D, Friedman JM, Wilson D, McFadden D, Pantzar J, Ritchie S, Hall JD (1993): Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 47:723-743.
48. van der Put NMJ, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ (1995): Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
49. van der Put NMJ, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, Blom HJ (1996): Decreased methylenetetrahydrofolate reductase activity due to the 677C-T mutation in families with spina bifida offspring. J Mol Med 74:691-694.
50. Waitzman NJ, Romano PS, Scheffler RM (1994): Estimates of the economic costs of birth defects. Inquiry 31:188-205.
51. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ (1996): Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube or limb. Teratology 53:261-267.
52. Werler MM, Shapiro S, Mitchell AA (1993): Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAIIA 269:1257-61.
53. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM (1995): A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.
54. Willis SA, Lacey SW, Weitman SD, Kamen BA, Nisen PD (1992): Folate receptor gene expression is tissue-specific and temporally-regulated. Cane Ther Control 2:223-230.
55. Windham GC, Bjerkedal T, Sever LE (1982): The association of twinning and neural tube defects: Studies in Los Angeles, California, and Norway. Acta Genet Med Gemellol 31:165-172.